Semaglutide is a glucagon-like peptide-1 receptor agonist (GLP-1 RA) that works by mimicking a hormone that the body uses to signal that it’s full or satisfied. It was originally approved for treating type 2 diabetes (under the Ozempic brand name), but the U.S. Food and Drug Administration soon approved it…
Updated: